Cooley advised Reneo, and Latham & Watkins advised the underwriters and placement agents.Reneo Pharmaceuticals, Inc. announced the pricing of its previously announced underwritten public offering of 6,875,000…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
